The Analysis of Checkpoint Capital L.P.'s Holdings & P&L


Currently, Checkpoint Capital L.P. holds 8 types of securities in its portfolio with a total value $278.7M. In the most recent quarter, they have increased their positions in RYTM (+235.0K shares, valued at $20.4M), ARGX (+11.0K shares, valued at $8.0M), SEPN (+100.3K shares, valued at $2.4M); decreased their positions in IRON (-166.3K shares, valued at $10.6M), RVMD (-107.5K shares, valued at $10.5M); initiated new positions in SEPN (+100.3K shares, valued at $2.4M), CRNX (+40.2K shares, valued at $1.5M), TRVI (+50.0K shares, valued at $596.5K).


1M P&L
+18.9M+6.16%
3M P&L
+15.3M+4.95%
HY P&L
-21.8M-6.28%

P&L figures are estimated based on reported 13F stock holdings and market price changes. They are approximations and may not reflect actual fund performance. Stock split events may also affect the accuracy of these calculations, and we cannot guarantee that all splits have been fully accounted for.

Top Holding Treemap

Top Industries by Value

1Biotechnology315.6M
100.0%

Top Industries by Stock Count

1Biotechnology6 stocks
100.0%
Stock Holdings
ARGX
ARGENX SE
7.75%
Shares153.0K
Event2026-03-31
Filed2026-05-15
RYTM
RHYTHM PHARMACEUTICALS INC
23.68%
Shares1.2M
Event2026-03-31
Filed2026-05-15
RVMD
REVOLUTION MEDICINES INC
-29.04%
Shares262.5K
Event2026-03-31
Filed2026-05-15
IRON
DISC MEDICINE INC
-36.72%
Shares286.7K
Event2026-03-31
Filed2026-05-15
CYTK
CYTOKINETICS INC
7.90%
Shares180.0K
Event2026-03-31
Filed2026-05-15
SEPN
SEPTERNA INC
New
Shares100.3K
Event2026-03-31
Filed2026-05-15
CRNX
CRINETICS PHARMACEUTICALS IN
New
Shares40.2K
Event2026-03-31
Filed2026-05-15
TRVI
TREVI THERAPEUTICS INC
New
Shares50.0K
Event2026-03-31
Filed2026-05-15

Call Option Holdings
No call option holdings data available

Put Option Holdings
No put option holdings data available